Total Payments
$7,744
2024 Payments
$511.73
Companies
31
Transactions
421
Medicare Patients
16,934
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$7,440 (96.1%)
Education$303.41 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,440 | 414 | 96.1% |
| Education | $303.41 | 7 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $665.37 | 18 | $0 (2023) |
| Amgen Inc. | $654.56 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $635.48 | 38 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $567.05 | 31 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $557.81 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $486.52 | 17 | $0 (2022) |
| Merck Sharp & Dohme LLC | $468.16 | 27 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $452.16 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $411.62 | 28 | $0 (2024) |
| Boston Scientific Corporation | $372.33 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $511.73 | 26 | Alnylam Pharmaceuticals Inc. ($115.88) |
| 2023 | $1,099 | 57 | Merck Sharp & Dohme LLC ($171.85) |
| 2022 | $1,608 | 95 | Boston Scientific Corporation ($161.77) |
| 2021 | $991.01 | 62 | Amarin Pharma Inc. ($170.25) |
| 2020 | $905.26 | 53 | BIOTRONIK INC. ($129.07) |
| 2019 | $925.67 | 37 | Abbott Laboratories ($326.62) |
| 2018 | $762.89 | 33 | Braemar Manufacturing, LLC ($105.19) |
| 2017 | $941.11 | 58 | Janssen Pharmaceuticals, Inc ($159.96) |
All Payment Transactions
421 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Genetic Disease | ||||||
| 09/10/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $29.18 | General |
| Category: Medical Device | ||||||
| 09/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $10.60 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/23/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Genetic Disease | ||||||
| 06/12/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Genetic Disease | ||||||
| 05/08/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Genetic Disease | ||||||
| 04/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.04 | General |
| Category: Cardiovascular | ||||||
| 04/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $36.27 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/16/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: LUX-Dx_CRM | ||||||
| 04/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiology | ||||||
| 04/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/20/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $25.29 | General |
| Category: Medical Device | ||||||
| 03/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiovascular | ||||||
| 02/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Cardiology | ||||||
| 02/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/07/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Genetic Disease | ||||||
| 02/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Cardiovascular | ||||||
| 01/18/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 3,409 | 5,958 | $896,978 | $408,271 |
| 2022 | 28 | 3,785 | 6,836 | $973,704 | $475,940 |
| 2021 | 30 | 4,660 | 8,251 | $858,187 | $513,151 |
| 2020 | 32 | 5,080 | 9,413 | $902,996 | $532,016 |
Total Patients
16,934
Total Services
30,458
Medicare Billing
$1.9M
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 357 | 359 | $195,953 | $117,847 | 60.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 363 | 724 | $199,281 | $63,922 | 32.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 251 | 1,012 | $90,108 | $44,243 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 256 | 450 | $86,382 | $40,061 | 46.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 250 | 260 | $74,066 | $36,106 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 392 | 565 | $77,038 | $34,347 | 44.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 359 | 361 | $40,855 | $16,903 | 41.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 141 | 148 | $34,004 | $16,256 | 47.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 487 | 825 | $20,625 | $8,115 | 39.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 36 | 185 | $13,875 | $4,673 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $9,000 | $2,599 | 28.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 16 | 120 | $3,381 | $2,187 | 64.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 59 | 127 | $3,711 | $2,026 | 54.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 14 | 14 | $2,555 | $2,003 | 78.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 18 | 18 | $3,285 | $1,696 | 51.6% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 19 | 23 | $2,831 | $1,557 | 55.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 27 | 58 | $3,909 | $1,549 | 39.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 32 | 69 | $2,309 | $1,549 | 67.1% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 22 | 43 | $7,811 | $1,489 | 19.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 20 | 75 | $1,966 | $1,382 | 70.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 51 | 55 | $3,722 | $1,107 | 29.7% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 16 | 25 | $2,961 | $1,087 | 36.7% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 47 | 73 | $3,625 | $1,082 | 29.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 31 | 41 | $3,173 | $1,062 | 33.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 19 | 87 | $2,473 | $776.04 | 31.4% |
About Dr. Joan Siracuse, MD
Dr. Joan Siracuse, MD is a Cardiovascular Disease healthcare provider based in Sebring, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649252925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joan Siracuse, MD has received a total of $7,744 in payments from pharmaceutical and medical device companies, with $511.73 received in 2024. These payments were reported across 421 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,440).
As a Medicare-enrolled provider, Siracuse has provided services to 16,934 Medicare beneficiaries, totaling 30,458 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Sebring, FL
- Active Since 11/14/2005
- Last Updated 05/20/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1649252925
Products in Payments
- ELIQUIS (Drug) $574.81
- XARELTO (Drug) $557.81
- Repatha (Biological) $548.51
- VERQUVO (Drug) $468.16
- MULTAQ (Drug) $393.69
- ENTRESTO (Drug) $360.96
- Mitra Clip system (Device) $344.11
- ONPATTRO (Drug) $312.31
- LEQVIO (Drug) $274.52
- FARXIGA (Drug) $259.20
- Vascepa (Drug) $249.10
- Cardiac Monitoring Suite (Device) $198.34
- Kerendia (Drug) $175.68
- PRALUENT (Drug) $173.36
- JARDIANCE (Drug) $147.21
- BRILINTA (Drug) $134.40
- LifeVest (Device) $128.12
- NEXLETOL (Drug) $125.49
- MITRACLIP (Device) $119.94
- WATCHMAN Access System (Device) $116.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Sebring
Mr. Daniel Parnassa, Md, MD
Cardiovascular Disease — Payments: $15,855
Cardiovascular Disease $15,855
Dr. Rakesh Sharma, M.d, M.D
Cardiovascular Disease — Payments: $10,129
Cardiovascular Disease $10,129
Ramon Torres, Md, MD
Cardiovascular Disease — Payments: $6,611
Cardiovascular Disease $6,611
Dr. George Leef, Md, MD
Cardiovascular Disease — Payments: $5,594
Cardiovascular Disease $5,594
Harini Lakshman, Md, MD
Cardiovascular Disease — Payments: $4,683
Cardiovascular Disease $4,683
Dr. Laura Mosher, Md, MD
Cardiovascular Disease — Payments: $4,579
Cardiovascular Disease $4,579